Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-04-30

Clinical Trial Update: Study of Oral Vinorelbine Plus Capecitabine Versus Taxane-gemcitabine Combinations as 1st Line Chemotherapy in Metastatic Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial comparing oral vinorelbine plus capecitabine against taxane-gemcitabine combinations as first-line therapy in metastatic breast cancer, with resul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Capecitabine (capecitabine)
  • Gemcitabine (Gemcitabine)
  • PACLITAXEL (PACLITAXEL)
  • Vinorelbine (oral) (Vinorelbine)

Snippet

Sponsor: Pierre Fabre Medicament | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED | Results posted: 2024-04-30